| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.44B | 142.99B | 120.44B | 113.52B | 93.75B | 84.26B |
| Gross Profit | 118.72B | 115.24B | 98.44B | 103.25B | 89.19B | 73.23B |
| EBITDA | 26.85B | 27.75B | 26.14B | 22.01B | 25.66B | 15.50B |
| Net Income | 19.75B | 18.72B | 15.94B | 14.86B | 17.71B | 11.45B |
Balance Sheet | ||||||
| Total Assets | 7.64T | 7.53T | 7.97T | 7.31T | 7.54T | 7.79T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 898.94B | 1.36T | 1.20T | 1.75T | 2.01T |
| Total Debt | 1.27T | 1.21T | 1.47T | 776.55B | 1.27T | 2.20T |
| Total Liabilities | 7.18T | 7.08T | 7.48T | 6.86T | 7.07T | 7.30T |
| Stockholders Equity | 456.91B | 444.81B | 490.89B | 441.22B | 464.21B | 495.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 368.47B | -488.52B | 0.00 | 1.24T |
| Operating Cash Flow | 0.00 | 0.00 | 369.60B | -483.43B | 0.00 | 1.24T |
| Investing Cash Flow | 0.00 | -47.63B | -288.59B | -57.99B | 21.82B | -126.66B |
| Financing Cash Flow | 0.00 | -381.21B | 565.53B | -7.95B | 200.07B | -34.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥435.92B | 9.10 | 8.52% | 2.12% | 22.55% | 36.30% | |
76 Outperform | ¥351.21B | 9.60 | ― | 2.94% | 9.90% | 16.52% | |
68 Neutral | ¥282.21B | 9.68 | ― | 2.27% | 18.50% | 80.18% | |
68 Neutral | ¥429.57B | 11.65 | 3.95% | 2.19% | 12.38% | 17.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥433.36B | 14.75 | ― | 1.50% | 21.64% | 43.65% | |
65 Neutral | ¥235.62B | 8.20 | ― | 3.46% | 9.73% | 15.55% |